NCT01226472
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Stanford University Stanford, California, United States
Clinical trial condition
Lymphoma, T-Cell, Peripheral
Explore clinical trials studying Lymphoma, T-Cell, Peripheral. Study availability and eligibility vary by location and protocol.
235 public trials
60 recruiting studies
Lymphoma, T-Cell, Peripheral trial results
Completed
Safety Study to Evaluate Monoclonal Antibody KW-0761 in Subjects With Peripheral T-cell Lymphoma
NCT00888927
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Ronald Reagan UCLA Medical Center Los Angeles, California, United States
- Stanford Medical Center Stanford, California, United States
- Yale Comprehensive Cancer Center New Haven, Connecticut, United States
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
NCT01588015
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +198 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT05321147
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- University of Alabama at Birmingham- O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
- University of California at Irvine - Chao Family Comprehensive Cancer Center Orange, California, United States
- Goshen Health- Goshen Hospital Goshen, Indiana, United States
- Indiana University School of Medicine Indianapolis, Indiana, United States
NCT02168140
- Conditions
- Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin Lymphoma, +40 more
- Locations
-
- Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States
- Abramson Cancer Center Philadelphia, Pennsylvania, United States
NCT04858568
- Conditions
- Burkitt Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +42 more
- Locations
-
- Bedfordshire Hospitals NHS Foundation Trust Bedford, Bedfordshire, United Kingdom
- Portsmouth Hospitals University NHS Trust Portsmouth, Hampshire, United Kingdom
- University Hospital Southampton NHS Foundation Trust Southampton, Hampshire, United Kingdom
- Wye Valley NHS Trust Hereford, Herefordshire, United Kingdom
Completed
A Phase 2 Study of SP-02L in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
NCT02653976
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Hong Kong
- Nagoya, Aichi-ken, Japan
- Yoshida-gun, Fukui, Japan
- Isehara, Kanagawa, Japan
NCT05137847
- Conditions
- Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- Eisai Trial Site 3 Nagoya, Japan
- Eisai Trial Site 1 Osaka, Japan
- Eisai Trial Site 2 Tokyo, Japan
NCT03742921
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Nihon Seimei Hospital Osaka, Japan
Completed
Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies
NCT01523223
- Conditions
- Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), +82 more
- Locations
-
- Stanford University Stanford, California, United States